Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Dicerna Pharmaceuticals Inc | d657912d10k.htm |
| EX-31.1 - EX-31.1 - Dicerna Pharmaceuticals Inc | d657912dex311.htm |
| EX-32.1 - EX-32.1 - Dicerna Pharmaceuticals Inc | d657912dex321.htm |
| EX-21.1 - EX-21.1 - Dicerna Pharmaceuticals Inc | d657912dex211.htm |
| EX-31.2 - EX-31.2 - Dicerna Pharmaceuticals Inc | d657912dex312.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-193795 on Form S-8 of our report dated March 27, 2014, relating to the consolidated financial statements of Dicerna Pharmaceuticals, Inc. and its subsidiary appearing in this Annual Report on Form 10-K of Dicerna Pharmaceuticals, Inc. for the year ended December 31, 2013.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 27, 2014